The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.25

Today's change0.00 0.00%
Updated April 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.25

Today's change0.00 0.00%
Updated April 25 4:00 PM EDT. Delayed by at least 15 minutes.

aTyr Pharma Inc closed at (U.S.)$3.25.

Over the last five days, shares have gained 8.33% and 51.16% year to date. Shares have underperformed the S&P 500 by 32.34% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $3.25
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+51.16%
  • Volume0
  • Average volume (10-day)39,652
  • Average volume (1-month)46,910
  • Average volume (3-month)209,350
  • 52-week range(U.S.) $2.10 to (U.S.) $4.45
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.44
Updated April 25 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense13141516
Selling / general / administrative3344
Research & development9101112
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0------
Other operating expenses, total--------
Operating income-13-14-15-16
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-13-14-15-16
Income after tax-13-14-15-16
Income tax, total0------
Net income-13-14-15-16
Total adjustments to net income000--
Net income before extra. items-13-14-15-16
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-14-15-16
Inc. avail. to common incl. extra. items-13-14-15-16
Diluted net income-13-14-15-16
Dilution adjustment--------
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.53-0.58-0.65-0.68
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.53-0.58-0.65-0.68